喘中气道形态的决定因素:炎症和非炎症因素
Kaoruko Shimizu1, Naoya Tanabe2, Hirokazu Kimura1
1Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
喘患者的BMI较高,喘持续时间较长,支气管支气管支气管发生变化的气道树形态. 粘液塞和炎症等生物标志物也会影响呼吸道结构,影响肺功能.
科学领域:
- 肺部医学 肺部医学
- 放射学 放射学是一门学科.
- 生物标志物研究 生物标志物研究
背景情况:
- 喘可能导致气道树形态异常.
- 难以治疗的喘特征对呼吸道结构的影响尚未完全理解.
研究的目的:
- 用CT扫描在喘患者中识别影响呼吸道总分支数 (TAC) 的因素.
- 探索TAC与吸烟者和非吸烟者的血液/液生物标志物之间的关联.
主要方法:
- 来自北海道严重喘队列的CT扫描和肺功能测试的分析 (N=190).
- 评价TAC,粘液堵塞,支气管切除和对体指数 (Lund-Mackay分数).
- 用于评估 TAC,临床特征和生物标志物之间的关系的回归模型.
主要成果:
- 低TAC与高BMI,喘持续时间,粘液塞和更高的隆德-麦凯分数相关.
- 低TAC与空气流阻塞和通风异质性有关.
- 支气管切除与TAC增加相关,而吐/血液炎症标志物与TAC相反相关.
结论:
- 体重指数,喘持续时间,鼻炎和支气管炎是喘气道形态的关键决定因素.
- 炎症和非炎症因素,包括粘液塞,影响气道树结构.
- 生物标志物与喘中的呼吸道形态和肺功能变化有关.
更多相关视频
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
相关概念视频
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
